Be part of the knowledge.™

Neurology and Neurosurgery

10382

LikeLikedUnlike

Multiple Sclerosis Without Borders: Taking a Global View
NeuroFrontiers
Multiple Sclerosis Without Borders: Taking a Global View
- Andrew Wilner, MD, FACP, FAAN
  Peer
- Victor Rivera, MD
  Peer
Multiplex Proteomic Biomarkers in MS: Emerging Tools for Precision Care
NeuroFrontiers
Multiplex Proteomic Biomarkers in MS: Emerging Tools for Precision Care
- Raphael Schneider, MD, PhD, FRCPC, CIP
  Peer
Understanding Accelerated Biological Aging in Pediatric MS
NeuroFrontiers
Understanding Accelerated Biological Aging in Pediatric MS
- Jennifer Yang, MD
  Peer
Advancing MS Care with Multimodal Aging Signatures and Proteomic Biomarkers
NeuroFrontiers
Advancing MS Care with Multimodal Aging Signatures and Proteomic Biomarkers
- Adil Harroud, MD
  Peer
- Dylan Hamitouche
  Peer
- Ryan Quigley
  Peer
OCEANIC-STROKE Results: Asundexian for Secondary Stroke Prevention After Acute Non-Cardioembolic Stroke or High-Risk TIA
Global Neurology Academy
OCEANIC-STROKE Results: Asundexian for Secondary Stroke Prevention After Acute Non-Cardioembolic Stroke or High-Risk TIA
- Mike Sharma, MD, MSc, FRCPC
  Peer
Beyond the Primary Endpoint: What OCEANIC-STROKE Subtype Analyses Reveal About Asundexian’s Potential
Global Neurology Academy
Beyond the Primary Endpoint: What OCEANIC-STROKE Subtype Analyses Reveal About Asundexian’s Potential
- Ashkan Shoamanesh, MD
  Peer
advertisement

Q-Challenge™
Cases in Multiple Sclerosis
3 questions
advertisement

Tau and Neurodegeneration in Alzheimer’s Disease: Bridging Pathology and Clinical Progression Through Biomarkers
Medical Industry Feature
Tau and Neurodegeneration in Alzheimer’s Disease: Bridging Pathology and Clinical Progression Through Biomarkers
- Yuval Zabar, MD
  Peer
- Michelle Mielke, PhD
  Peer
- Henrik Zetterberg, MD, PhD
  Peer
Treating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA
Medical Industry Feature
Treating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA
Amyloid and Tau in Alzheimer’s Disease: Insights into Disease Progression
Medical Industry Feature
Amyloid and Tau in Alzheimer’s Disease: Insights into Disease Progression
- Holly M. Brothers, PhD
  Peer
- Niklas Mattsson-Carlgren, MD, PhD
  Peer
New Trial Device Opens Blood-Brain Barrier to Treat Glioblastoma
Medical Industry Feature
New Trial Device Opens Blood-Brain Barrier to Treat Glioblastoma
- Brian Gill, M.D.
  Peer
Reassessing the Full Clinical Picture of ADHD
Medical Industry Feature
Reassessing the Full Clinical Picture of ADHD
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Ann Childress, MD
  Peer
MMN in Practice: A Rare Motor Neuropathy Often Misdiagnosed
Medical Industry Feature
MMN in Practice: A Rare Motor Neuropathy Often Misdiagnosed
- Jennifer Caudle, DO, FACOFP
  Peer
- Katie Beadon, MD, MASc, FRCPC
  Peer

Medical News
M-PACT: AI-Driven Methylation Liquid Biopsy for Pediatric CNS Tumor Classificat…
02/19/2026
Medical News
Neuronal IDOL deletion links LDLR/APOE regulation to reduced amyloid and synapt…
02/16/2026
Medical News
Preclinical Insights Into CD4+ CAR-T Targeting Amyloid Beta in Alzheimer's Dise…
02/13/2026
Medical News
New Findings on Visual Dysfunction in Parkinson's Disease
02/12/2026
Medical News
Understanding Parkinson’s Disease and the Brain’s Action Network
02/11/2026
Medical News
Speed-Focused Cognitive Training With Booster Sessions Linked to Lower Dementia…
02/10/2026

Program Chapters

Segment Chapters

Playlist:

Recommended